In a new study, researchers examined the Renal Activity Index for Lupus (RAIL) diagnostic tool to assess its success for ...

Approval based on phase II NOBILITY and phase III REGENCY studies showing superiority of Gazyva/Gazyvaro over standard ...

Roche has received EC approval for its humanised monoclonal antibody Gazyva, in combination with mycophenolate mofetil (MMF).

Basel: Roche has announced that the European Commission has approved Gazyva/Gazyvaro (obinutuzumab) in combination with ...

A rare and life-threatening kidney disease in children finally has an effective therapy, thanks in large part to pioneering ...

Coherus Oncology, Inc. (NASDAQ: CHRS) today announced compelling six-year overall survival (OS) follow-up results from the Phase 3 JUPITER-02 trial evaluating LOQTORZI® (toripalimab-tpzi) plus ...

A rare and life-threatening kidney disease in children finally has an effective therapy, thanks in large part to pioneering ...

The history of Hollywood is filled with talented performers whose lives were tragically cut short before they could fully ...

Kidney diseases, including chronic kidney disease (CKD) and acute kidney injury (AKI), represent a major global public health burden. These diseases cause ...

Background In Nigeria and other resource-limited countries (RLCs), paediatric kidney transplantation (PKT) uptake remains low ...

Sobi® (STO: SOBI), today announced its participation at the 65th American Society of Hematology (ASH) Annual Meeting, taking place on 6 – 9 December in Orlando, Florida. At this year’s meeting, Sobi ...

The donation from Don and Anne Edwards aims to speed research, treatment and diagnosis for children with rare and genetic ...